Stratifying risk in prostate and cervical cancer

被引：0
|
作者：
机构：
来源：
Nature Reviews Cancer | 2006年 / 6卷 / 12期
关键词：
D O I：
10.1038/nrc2043
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：902 / 902
相关论文
共 50 条
  • [1] Stratifying Cervical Cancer Risk With Registry Data
    Baltzer, Nicholas
    Sundstrom, Karin
    Nygard, Jan
    Nygard, Mari
    Dillner, Joakim
    Komorowski, Jan
    [J]. 2018 IEEE 14TH INTERNATIONAL CONFERENCE ON E-SCIENCE (E-SCIENCE 2018), 2018, : 288 - 289
  • [2] THE ROLE OF MPMRI IN STRATIFYING PATIENTS WITH INCREASED RISK OF PROSTATE CANCER
    Nathalie, Lauwers
    Claus, Filip
    Joniau, Steven
    Albersen, Maarten
    Els, Vanhoutte
    Dewever, Liesbeth
    Oyen, Raymond
    Moris, Lisa
    Mai, Cindy
    Milenkovic, Uros
    Everarts, Wouter
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E338 - E338
  • [3] Sratifying risk in prostate and cervical cancer
    不详
    [J]. NATURE REVIEWS CANCER, 2006, 6 (12)
  • [4] Performance assessment of radiogenomics machine learning models for stratifying prostate cancer risk
    Payan, N.
    Murphy, R. G.
    Jain, S.
    Hounsell, A. R.
    Osman, S.
    O'Sullivan, J. M.
    Prise, K. M.
    McGarry, C. K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1562 - S1563
  • [5] Do you need further assistance in diagnosing and risk stratifying prostate cancer?
    Davis, John W.
    [J]. BJU INTERNATIONAL, 2019, 124 (04) : 547 - 547
  • [6] Stratifying Risk for Men With Low-Volume Intermediate-Risk Prostate Cancer Reply
    Patel, Hiten D.
    Tosoian, Jeffrey J.
    Carter, H. Ballentine
    Epstein, Jonathan I.
    [J]. JAMA ONCOLOGY, 2018, 4 (08) : 1133 - 1134
  • [7] The role of transperineal template prostate mapping biopsies in risk-stratifying men with localised prostate cancer
    Ahmed, H.
    Stevens, D.
    Barbouti, O.
    Zacharakis, E.
    Pendse, D.
    Illing, R.
    Allen, C.
    Freeman, A.
    Emberton, M.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 274 - 274
  • [8] Early stage prostate cancer treated with radiation therapy: Stratifying an intermediate risk group
    Lattanzi, JP
    Hanlon, AL
    Hanks, GE
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 38 (03): : 569 - 573
  • [9] CLINICAL FACTORS PREDICTING AND STRATIFYING THE RISK OF LYMPH NODE INVASION IN LOCALIZED PROSTATE CANCER
    De Luyk, Nicolo
    Porcaro, Antonio Benito
    Corsi, Paolo
    Sebben, Marco
    Tafuri, Alessandro
    Cacciamani, Giovanni
    De Marco, Vincenzo
    Balzarro, Matteo
    Siracusano, Salvatore
    Artibani, Walter
    [J]. ANTICANCER RESEARCH, 2017, 37 (04) : 2124 - 2124
  • [10] Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer
    Kwon, Young Suk
    Han, Christopher Sejong
    Yu, Ji Woong
    Kim, Sinae
    Modi, Parth
    Davis, Rachel
    Park, Ji Hae
    Lee, Paul
    Ha, Yun-Sok
    Kim, Wun-Jae
    Kim, Isaac Yi
    [J]. CLINICAL GENITOURINARY CANCER, 2016, 14 (01) : E1 - E8
12345